
4-Hydroxymephenytoin
CAS No. 61837-65-8
4-Hydroxymephenytoin( (+/-)-4'-Hydroxymephenytoin )
Catalog No. M26029 CAS No. 61837-65-8
4-Hydroxymephenytoin is the metabolism of an antiepileptic drug mephenytoin. Mephenytoin is used as a CYP2C19 substrate.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 65 | Get Quote |
![]() ![]() |
10MG | 102 | Get Quote |
![]() ![]() |
25MG | 205 | Get Quote |
![]() ![]() |
50MG | 335 | Get Quote |
![]() ![]() |
100MG | 537 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product Name4-Hydroxymephenytoin
-
NoteResearch use only, not for human use.
-
Brief Description4-Hydroxymephenytoin is the metabolism of an antiepileptic drug mephenytoin. Mephenytoin is used as a CYP2C19 substrate.
-
Description4-Hydroxymephenytoin is the metabolism of an antiepileptic drug mephenytoin. Mephenytoin is used as a CYP2C19 substrate.(In Vitro):4-Hydroxymephenytoin is a metabolism of mephenytoin, which is an antiepileptic drug, and used as a CYP2C19 substrate. 4-Hydroxymephenytoin is used for developing UltraPerformance LC (UPLC) tandem mass spectrometry assays for evaluating CYP probe drugs and their relevant metabolites in human urine or plasma samples.
-
In Vitro——
-
In Vivo——
-
Synonyms(+/-)-4'-Hydroxymephenytoin
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number61837-65-8
-
Formula Weight234.255
-
Molecular FormulaC12H14N2O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (426.89 mM)
-
SMILESCCC1(NC(=O)N(C)C1=O)c1ccc(O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sonneck M, et al. Crystal structure of (E)-undec-2-enoic acid. Acta Crystallogr E Crystallogr Commun. 2015 May 28;71(Pt 6):o426-7.
molnova catalog



related products
-
PF-04937319
PF-04937319 is an activator of glucokinase (EC50 =154.4 ?μM). PF-04937319 maintains glucose-lowering efficacy while mitigating the risk of hypoglycemia observed with many other glucokinase activators. PF-04937319 can be used in research on the treatment of type 2 diabetes mellitus.
-
3-Chloropropiophenon...
3-Chloropropiophenone is a small molecular compound.
-
GAC0003A4
GAC0003A4 is a potent LXR inverse agonist with antitumor activity that inhibits the transcription of LXR proteins.GAC0003A4 degrades LXRβ proteins and inhibits the proliferation of PDAC cells in a dose-dependent manner.